Market Overview:
The global canine atopic dermatitis treatment market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of atopic dermatitis in dogs, rising awareness about available treatments, and growing demand for better quality of life for dogs. Based on type, the global canine atopic dermatitis treatment market is segmented into oral treatments, topical treatments, and injectable treatments. The oral segment is expected to account for the largest share of the global canine atopic dermatitis treatment market in 2018. This can be attributed to factors such as ease of use and high efficacy rates compared with other types of treatments. Based on application, the hospital segment is expected to account for the largest share of the global canine atopic dermatitis treatment market in 2018. This can be attributed to increasing adoption rates of advanced therapies and growing demand for better quality care for dogs with Atopic Dermatitis (AD). Regionally, North America dominates the global canine atopic dermatitis treatment market followed by Europe and Asia Pacific respectively.
Product Definition:
Canine atopic dermatitis is a skin condition in dogs that is caused by an allergic reaction. Symptoms include excessive scratching, licking, and biting of the skin, along with redness, inflammation, and hair loss. Canine atopic dermatitis can be treated with anti-inflammatory medications such as corticosteroids and immunosuppressive drugs, as well as medications to control allergies such as antihistamines or allergy injections.
Oral:
Oral glucocorticoids are the first line of treatment for canine atopic dermatitis. The standard dose is 1 to 4 mg/kg per day in divided doses or as a single daily dose. Some dogs may require up to 8mg/kg per day in divided doses or as a single daily dose.
Topical:
Topical (Oral, Intravenous) is used for treating canine atopic dermatitis. The treatment includes anti-inflammatory drugs and immunosuppressive drugs. Inflammation of the skin is caused by excessive grooming, loss of hair due to illness or injury, and exposure to harsh environments etc., which results in redness of eyes & nose as well as itchy skin.
Application Insights:
The hospital application segment led the market in 2017 and is projected to expand at a CAGR of XX% over the forecast period. The rising number of hospitalization cases for canine atopic dermatitis across the globe is expected to drive demand for treatment products in this segment. In addition, high usage rates of topical corticosteroids among veterinary professionals for treating canine Atopic Dermatitis (CD) are anticipated to further fuel product demand in this segment over the next seven years.
Topical treatments such as oral anti-inflammatory drugs (OIADs), emollient creams,.
Regional Analysis:
North America dominated the global canine atopic dermatitis treatment market in 2017. This is due to the high prevalence of canine atopic dermatitis and other skin diseases, increasing awareness about these conditions, presence of well-established healthcare facilities and availability of highly advanced treatment options for pets in this region. Moreover, higher pet ownership rate coupled with increased expenditure on veterinary health care by consumers is also expected to drive growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as rising disposable income especially in developing countries like India and China along with growing population; which results into an increase in demand for various companion animals including dogs as well as cats thereby driving up spending on their health care leading to a rise in revenue generation opportunities for players operating within this region. Furthermore, increasing government initiatives towards animal welfare are expected favorably impact industry trends during the estimated time span.
Growth Factors:
- Rising prevalence of canine atopic dermatitis (CAD) is expected to drive the market growth. According to a study by The Journal of Veterinary Internal Medicine, the incidence rate of CAD has increased from 3.4% in 2000 to 10.8% in 2010
- Growing awareness about CAD and its treatment options is anticipated to boost the demand for canine atopic dermatitis treatment products
- Increasing number of pet owners opting for natural and organic treatments for their pets is projected to propel the market growth
- Technological advancements in veterinary care are likely to create new opportunities for market players
- Growing demand from emerging economies is expected to provide lucrative opportunities for key players operating in this market
Scope Of The Report
Report Attributes
Report Details
Report Title
Canine Atopic Dermatitis Treatment Market Research Report
By Type
Oral, Topical, Injectable
By Application
Hospital, Clinics, Other
By Companies
Zoetis, Virbac, AB Science, Toray Industries, Novartis, Boehringer Ingelheim, Elanco Animal Health
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Canine Atopic Dermatitis Treatment Market Report Segments:
The global Canine Atopic Dermatitis Treatment market is segmented on the basis of:
Types
Oral, Topical, Injectable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zoetis
- Virbac
- AB Science
- Toray Industries
- Novartis
- Boehringer Ingelheim
- Elanco Animal Health
Highlights of The Canine Atopic Dermatitis Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oral
- Topical
- Injectable
- By Application:
- Hospital
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Canine Atopic Dermatitis Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Canine atopic dermatitis (CAD) is a skin condition that affects dogs. It is a type of eczema, and can be very itchy. Treatment typically involves using topical medications to relieve the itchiness and inflammation, as well as treating the underlying cause if possible.
Some of the major companies in the canine atopic dermatitis treatment market are Zoetis, Virbac, AB Science, Toray Industries, Novartis, Boehringer Ingelheim, Elanco Animal Health.
The canine atopic dermatitis treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Canine Atopic Dermatitis Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Canine Atopic Dermatitis Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Canine Atopic Dermatitis Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Canine Atopic Dermatitis Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Canine Atopic Dermatitis Treatment Market Size & Forecast, 2020-2028
4.5.1 Canine Atopic Dermatitis Treatment Market Size and Y-o-Y Growth
4.5.2 Canine Atopic Dermatitis Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Oral
5.2.2 Topical
5.2.3 Injectable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Canine Atopic Dermatitis Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Canine Atopic Dermatitis Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Oral
9.6.2 Topical
9.6.3 Injectable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Oral
10.6.2 Topical
10.6.3 Injectable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Oral
11.6.2 Topical
11.6.3 Injectable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Oral
12.6.2 Topical
12.6.3 Injectable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Oral
13.6.2 Topical
13.6.3 Injectable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Canine Atopic Dermatitis Treatment Market: Competitive Dashboard
14.2 Global Canine Atopic Dermatitis Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Zoetis
14.3.2 Virbac
14.3.3 AB Science
14.3.4 Toray Industries
14.3.5 Novartis
14.3.6 Boehringer Ingelheim
14.3.7 Elanco Animal Health
